Doddie Weir and the trustees of My Name’5 Doddie Foundation have agreed their first investment into MND Research.
The Foundation will support the work of Chris Shaw, Professor of Neurology and Neurogenetics, and his team at King’s College London who are spearheading Gene Therapy for Sporadic Motor Neurone Disease.
They have agreed an investment of £400,000 to help Professor Shaw and his work.
This follows the independent report commissioned by the Trustees to help steer their strategy for investing in research into the causes of MND and seek potential cures.
Professor Shaw said: “This is absolutely terrific news. This is a game changing commitment by the My Name'5 Doddie Foundation to employ the latest gene therapy technologies to develop revolutionary new treatments for people with motor neurone disease. This is a high risk, but potentially very high return, initiative that could make a dramatic impact on the course of this dreadful disease."
Doddie Weir said: “We have received incredible support since we launched the Foundation in November and it was important for us to take time and consider how best to use the funds we have raised wisely. Everyone has been so supportive and worked very hard to give us this opportunity and I would like to thank each and every one of those who has given their time, energy and hard earned money to allow us to move forward and invest in research.
“I have said it before but while it may be too late to find something that can help me, I am committed to doing everything I can to help find a cure.”